Wim Ceelen is a surgical oncologist with an interest in advanced or recurrent GI cancer, soft tissue retroperitoneal cancers, ovarian cancer, and peritoneal metastasis. He Ieads lead the Experimental Surgery lab at Ghent University, which has between 4 and 8 PhD students, one postdoc, and 4 support staff. We perform clinical, translational, and basic research in the fields of intraperitoneal drug delivery, novel treatments of peritoneal metastasis, biophysical properties of cancer tissue, and lymphatic metastasis in colon cancer.
Prof. Jeroen Missinne is part-time professor at Ghent University and also employed at CMST, an imec-affiliated lab at Ghent University. His research involves laser fabrication technology, optical sensors and flexible/stretchable photonics and electronics.
Frank Speleman is professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is the study of perturbed gene regulatory processes in paediatric cancer, more specifically neuroblastoma and T-ALL.
Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.
Frauke Coppieters is assistant professor within RARE-MED, a Ghent University multidisciplinary consortium for basic and translational research on precision medicine for rare diseases (Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences). Her research focuses on retinal disease modelling and new genetic therapies for inherited blindness.
Bert Devriendt is an assistant professor at the laboratory of Immunology, Faculty of Veterinary Medicine. His research focuses on host-pathogen interactions in the gut and the delivery of therapeutics to the gut tissues. His group develops gut organoids to facilitate this research.
Prof. Jan Vanfleteren is a Principal Member of Technical Staff (PMTS) at Imec and a part-time professor at Ghent University. He is involved in the development of novel microsystem technologies, especially for wearable and implantable electronics, microfluidics, and tissue engineering applications.
Tom Coenye leads the Laboratory of Pharmaceutical Microbiology. His research is centered around microbial biofilm formation, the evaluation of novel strategies to prevent biofilm formation and/or eradicate existing biofilms, and the molecular basis of tolerance and resistance in biofilms.